Enliven Therapeutics, Inc. (ELVN)

27.56 +0.36 (+1.30%) USD  |  NASDAQ  |  Jan 22, 13:20
More

Enliven Therapeutics Return on Net Operating Assets

Return on Net Operating Assets Chart

View Return on Net Operating Assets for ELVN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Return on Net Operating Assets Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Return on Net Operating Assets Range, Past 5 Years

View Return on Net Operating Assets Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Return on Net Operating Assets Benchmarks

View Return on Net Operating Assets Benchmarks
Start Trial
Coherus Oncology, Inc. Upgrade
Allogene Therapeutics, Inc. Upgrade
Pyxis Oncology, Inc. Upgrade
CEL-SCI Corp. Upgrade
AIM ImmunoTech, Inc. Upgrade

Return on Net Operating Assets Related Metrics

Return on Equity Upgrade
Return on Assets Upgrade
Return on Invested Capital Upgrade